首页> 外国专利> FXIII DETECTION FOR VERIFYING SERUM SAMPLE AND SAMPLE SIZE AND FOR DETECTING DILUTION

FXIII DETECTION FOR VERIFYING SERUM SAMPLE AND SAMPLE SIZE AND FOR DETECTING DILUTION

机译:FXIII检测,用于验证血清样本和样本大小以及检测稀释度

摘要

Analyses of serum samples for the presence and amount of either of the two subunits of human Factor XIII protein are used as a means of eliminating a significant source of error that arises in the testing of serum and plasma. For serum samples, a negative result of an analysis for the presence of subunit a is a means of verifying that a sample is indeed serum, while a negative or positive result for subunit a serves to distinguish serum (negative) from plasma (positive). A positive result for the presence of subunit b is a means of verifying that the sample is either serum or plasma and not any other biological fluid. A quantitative analysis of subunit b is a means of verifying that the sample is of the intended volume rather than having been reduced in volume due to improper sampling. A quantitative analysis of subunit b is also a means of verifying the dilution of a sample of either serum or plasma.
机译:血清样品中人因子XIII蛋白两个亚基之一的存在和数量的分析被用作消除在血清和血浆测试中出现的重要误差来源的一种手段。对于血清样品,分析亚基a的存在的阴性结果是验证样品确实为血清的手段,而亚基a的阴性或阳性结果可用来区分血清(阴性)与血浆(阳性)。 b亚基存在的阳性结果是验证样品是血清还是血浆而不是任何其他生物流体的手段。对亚基b进行定量分析是一种验证样品是否达到预期体积而不是由于不适当采样而导致体积减小的方法。亚基b的定量分析也是验证血清或血浆样品稀释度的一种手段。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号